September 2026 results published; physical-share transfer window noted
MOREPENLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Morepen Laboratories said the board approved unaudited standalone and consolidated results for the quarter and six months ended 30 September 2026. The results were published on 28 October 2026 in Financial Express and Jansatta and are also on the company website. The headline also notes a special window for physical-share transfers and dematerialisation, but clear dates and financial figures are not readable.
This mainly confirms publication. Investors should assess the reported profit, revenue and cash flow, and review the physical-share transfer terms.